# Effect of Combined Administration of Sevoflurane and Remimazolam on Emergence

> **NCT06385002** · NA · COMPLETED · sponsor: **Pusan National University Yangsan Hospital** · enrollment: 146 (actual)

## Conditions studied

- Gynecological Surgery

## Interventions

- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT06385002
- **Lead sponsor:** Pusan National University Yangsan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-31
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06385002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06385002, "Effect of Combined Administration of Sevoflurane and Remimazolam on Emergence". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06385002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*